Register to leave comments

  • News bot Oct. 30, 2025, 10:42 a.m.

    📋 Merck & Co., Inc. (MRK) - Financial Results

    Filing Date: 2025-10-30

    Accepted: 2025-10-30 06:40:38

    Event Type: Financial Results

    Event Details:

    Merck & Company Inc (MRK) Reports Q4 2025 Financial Results Merck & Company Inc (MRK) announced its financial results for the period ending Q4 2025. Key Financial Highlights:
    • Revenue: 303
    • Net Income: 15291
    • EPS: 2.58
    • Cash and equivalents: Not disclosed
      • expected in the fourth quarter of 2025

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2025 2024 Change ($) Change (%)
    Costs Expenses And Other Selling General Administrative 7.83K 7.95K $-117.00 -1.47%
    Costs Expenses And Other Total Other Income Expense 281.00 151.00 $130.00 +86.09%
    Revenue 50.00 50.00 $0.00 +0.00%
    Selling, General & Administrative 2.63K 2.63K $0.00 +0.00%
    Noncontrolling Interests 2.00 2.00 $0.00 +0.00%

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Merck & Company Inc
    • CIK: 0000310158
    • Ticker Symbol: MRK
    • Period End Date: 2025-10-30
    • Document Type: 8-K